RenovoRx, Inc. (RNXT) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$10.97M | -20.3% |
| 2024 | -$9.12M | +11.0% |
| 2023 | -$10.26M | -16.4% |
| 2022 | -$8.81M | -48.9% |
| 2021 | -$5.92M | -67.7% |
| 2020 | -$3.53M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$10.97M | -20.3% |
| 2024 | -$9.12M | +11.0% |
| 2023 | -$10.26M | -16.4% |
| 2022 | -$8.81M | -48.9% |
| 2021 | -$5.92M | -67.7% |
| 2020 | -$3.53M | — |